Search

Beacon Therapeutics announced positive results from their phase 2 gene therapy trial for X-linked retinitis pigmentosa (XLRP) caused by mutations in the RPGR gene.

• News
• Retinitis pigmentosa

This October, join Retina UK on Halloween weekend (28 and 29 October 2023) and face your fears by taking on a Halloween skydive at various airfields around the UK.

• Extreme challenges
• Various

This November, join Retina UK on Bonfire weekend (4 and 5 November 2023) and face your fears by taking on a Bonfire skydive at various airfields around the UK.

• Extreme challenges
• Various

Various dates and locations available. Skydiving is an exhilarating experience, and you can do this while supporting our cause.

• Extreme challenges
• Various

Inside this edition, register now for our AI webinar on 7 December with Dr Nikolas Pontikos.

• Look Forward
• Audio
• Written

Inside this edition, set yourself a challenge in 2024, plus find out about our brand new lottery.

• Look Forward
• Audio
• Written

These frequently asked questions should provide a response for most of the queries you might raise.

Different inherited sight loss conditions present noticeable symptoms at different times.

• Written

If you have a child with a visual impairment joining your class, you may have questions about how best you can teach and help them.

• Written

Mini-retinas are essentially mini eyeballs in a dish. They contain all of the cell types in the human retina and we can perform many experiments on these to figure out the missing pieces in the puzzle.

• Webinar
• Audio
• Video